QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,036 signal articles · 531 in last 24h · 103,484 total before filter · latest 14m ago
531last 24h
2514last 7d
484● bullish (7d)
257● bearish (7d)
197publishers
AllMacro243Earnings1482M&A141Regulatory16Product4Analyst29
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Coinbase beats much of customer lawsuit over US token sales
Reuters5d agobullish
Coinbase beats much of customer lawsuit over US token sales

NEW YORK, July 30 (Reuters) - Coinbase won the dismissal on Thursday of much of a lawsuit in which customers accused the largest U. ‌cryptocurrency exchange of illegally selling securities without registering as an exchange or ‌broker-dealer.

FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System
Benzinga12d agobullish
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System

The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing clearance encompasses multiple general surgery...

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC
Insider Monkey38d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]

AI stock surges amid multi-million-dollar lawsuit
TheStreet42d agobullish
AI stock surges amid multi-million-dollar lawsuit

Shares of Hut 8 (NASDAQ: HUT) tumbled in the pre-market session on June 22 but recovered lost ground after the morning bell. The stock fell about 7% to $112.50 after closing the prior day down 2.73% at $121.04. But at press time, the shares were trading 2.36% higher inraday and trading near ...